Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism
Michael P. Bogenschutz, Alyssa A. Forcehimes
Journal of Humanistic Psychology October 16, 2016 DOI: 10.1177/0022167816673493 via OpenAlex
Summary
AI-generated from the abstractResearch into the clinical value of classic hallucinogens and other psychedelics has increased markedly in the past two decades. Effective experimental and clinical use requires psychotherapeutic models tailored to the disorder and integrated with the drug's pharmacological effects. This paper provides an overview of the history of psychedelic-assisted treatment, reviews known therapeutic mechanisms, and considers the purposes of psychotherapy in research and clinical contexts. The authors describe a therapy model they developed for a trial of psilocybin-assisted treatment for alcoholism and discuss advantages and disadvantages of alternative models, emphasizing the need for research to determine the most effective approaches for established indications.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Psychotherapist Hallucinogen Context archaeology Psychology |
| Citations | 96 |
| Key finding | Effective psychedelic-assisted treatment requires psychotherapeutic models that are disorder-appropriate and integrated with the pharmacological component. |
Abstract
Research activity on the potential clinical value of classic hallucinogens and other psychedelics has increased markedly in the past two decades, and promises to continue to expand. Experimental study of hallucinogen-assisted treatment, and any future clinical use, requires the development of psychotherapeutic models that are appropriate to the disorder being treated and effectively integrated with the pharmacologic component of the treatment. To provide a framework for thinking about possible treatment models, we provide an overview of the history of psychedelic-assisted treatment, review what is known about the therapeutic mechanisms of these treatments, and consider the various purposes of psychotherapy in the context of both research and clinical use of psychedelic-assisted treatment. We then provide a description of a therapy model we have developed and are currently using in a trial of psilocybin-assisted treatment for alcoholism. Finally, we discuss advantages and disadvantages of a range of alternative models, emphasizing the need for research to determine the most effective treatment models for any indications for which efficacy becomes established.